Page last updated: 2024-08-26

hepsulfam and Neutropenia

hepsulfam has been researched along with Neutropenia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hillyer, CD; Kim, BK; McClure, HM; Myers, LA; Orkin, JL; Saral, R; Srinivasiah, J; Strobert, EA; Swenson, RB; Winton, EF	1
Cheung, E; Hanson, SR; Harker, LA; Kelly, AB; Marzec, UM; Nichol, JL; Stead, RB; Tomer, A	1
Donehower, RC; Ettinger, DS; Forastiere, AA; Grochow, LB; Hendricks, CB; Lubejko, B; McGuire, WP; Rowinsky, EK; Sartorius, S	1

Trials

1 trial(s) available for hepsulfam and Neutropenia

Article	Year
Phase I and pharmacokinetic study of hepsulfam (NSC 329680). Cancer research, 1991, Nov-01, Volume: 51, Issue:21 Topics: Adult; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Sulfonic Acids; Thrombocytopenia	1991

Other Studies

2 other study(ies) available for hepsulfam and Neutropenia

Article	Year
Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model. Blood, 1994, Jul-01, Volume: 84, Issue:1 Topics: Animals; Bone Marrow; Female; Hematopoiesis; Hematopoietic Stem Cells; Hemoglobins; Interleukin-3; Interleukin-6; Macaca mulatta; Male; Neutropenia; Recombinant Proteins; Reticulocytes; Sulfonic Acids; Thrombocytopenia	1994
Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor. Blood, 1997, Jan-01, Volume: 89, Issue:1 Topics: Alkylating Agents; Animals; Bone Marrow; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Macaca mulatta; Male; Megakaryocytes; Neoplasm Proteins; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Proto-Oncogene Proteins; Receptors, Cytokine; Receptors, Thrombopoietin; Recombinant Proteins; Sulfonic Acids; Thrombocytopenia; Thrombopoietin; Time Factors	1997

Article

Year

Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model.

Blood, 1994, Jul-01, Volume: 84, Issue:1

Topics: Animals; Bone Marrow; Female; Hematopoiesis; Hematopoietic Stem Cells; Hemoglobins; Interleukin-3; Interleukin-6; Macaca mulatta; Male; Neutropenia; Recombinant Proteins; Reticulocytes; Sulfonic Acids; Thrombocytopenia

1994

Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.

Blood, 1997, Jan-01, Volume: 89, Issue:1

Topics: Alkylating Agents; Animals; Bone Marrow; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Macaca mulatta; Male; Megakaryocytes; Neoplasm Proteins; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Proto-Oncogene Proteins; Receptors, Cytokine; Receptors, Thrombopoietin; Recombinant Proteins; Sulfonic Acids; Thrombocytopenia; Thrombopoietin; Time Factors

1997